Hematologic Malignancy
Acute Leukemia
CI-CAN-00000399Explore in graph →
Hematologic1,259 active trials30 approved drugs323 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000399Explore in graph →
Clinical trials
4,653 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (718)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01819792 | Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia(LAMVIRE) | completed | Phase 4 | 119 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT01906671 | Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid | unknown | Phase 4 | 16 | Kjeld SchmiegelowOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01347996 | Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia | completed | Phase 4 | 84 | Cytovia, Inc.OTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00576472 | Learning Impairments Among Survivors of Childhood Cancer | completed | Phase 4 | 469 | St. Jude Children's Research HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT03150134 | Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients | unknown | Phase 4 | 100 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 12, 2017 | clinicaltrials |
| NCT00686543 | Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | completed | Phase 4 | 75 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 7, 2017 | clinicaltrials |
| NCT03026842 | Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21) | unknown | Phase 4 | 180 | The First Hospital of Jilin UniversityOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT02953730 | The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents | completed | Phase 4 | 9 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT02894645 | Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | unknown | Phase 4 | 500 | National University Hospital, SingaporeOTHER | 2 | Sep 30, 2016 | clinicaltrials |
| NCT02027064 | Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT | unknown | Phase 4 | 40 | Peking University People's HospitalOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT00526175 | LAL-BR/2001: Study Treatment to Low Risk ALL | completed | Phase 4 | 150 | PETHEMA FoundationOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01873807 | HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL(HITA) | unknown | Phase 4 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT02277847 | Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia | unknown | Phase 4 | 400 | Guangdong Provincial People's HospitalOTHER | 0 | Oct 29, 2014 | clinicaltrials |
| NCT00408278 | Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) | completed | Phase 4 | 300 | PETHEMA FoundationOTHER | 3 | Oct 28, 2014 | clinicaltrials |
| NCT00504764 | Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) | completed | Phase 4 | 60 | PETHEMA FoundationOTHER | 1 | Oct 28, 2014 | clinicaltrials |
| NCT00526409 | LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia(LAL-AR-N-2005) | completed | Phase 4 | 40 | PETHEMA FoundationOTHER | 1 | Oct 28, 2014 | clinicaltrials |
| NCT01358253 | Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia | completed | Phase 4 | 100 | Ruijin HospitalOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01198054 | LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML) | terminated | Phase 4 | 4 | PETHEMA FoundationOTHER | 1 | Apr 7, 2014 | clinicaltrials |
| NCT01587430 | 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia | unknown | Phase 4 | 245 | National Research Center for Hematology, RussiaNETWORK | 1 | Apr 7, 2014 | clinicaltrials |
| NCT02024308 | AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy | unknown | Phase 4 | 62 | Changhai HospitalOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT01990807 | Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia | unknown | Phase 4 | 20 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT01041040 | LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) | completed | Phase 4 | 200 | PETHEMA FoundationOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00114348 | ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia | completed | Phase 4 | 338 | Charite University, Berlin, GermanyOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01339988 | Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) | unknown | Phase 4 | 10 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Apr 21, 2011 | clinicaltrials |
| NCT00199004 | Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab | completed | Phase 4 | 60 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00846703 | The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia | unknown | Phase 4 | 600 | Sun Yat-sen UniversityOTHER | 1 | Mar 8, 2010 | clinicaltrials |
| NCT00222612 | Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 | unknown | Phase 4 | 2,100 | University of OxfordOTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00464217 | Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years | completed | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT00526305 | LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive | completed | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT00192673 | Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses | unknown | Phase 4 | 85 | Nordic Society for Pediatric Hematology and OncologyOTHER | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00797810 | Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults | unknown | Phase 4 | 25 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00494897 | PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia | completed | Phase 4 | 374 | PETHEMA FoundationOTHER | 1 | May 19, 2009 | clinicaltrials |
| NCT00487448 | SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia(FLAG-IDA) | completed | Phase 4 | 200 | PETHEMA FoundationOTHER | 1 | Nov 19, 2008 | clinicaltrials |
| NCT00488709 | Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia(FLAT) | completed | Phase 4 | 47 | PETHEMA FoundationOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00465933 | Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) | completed | Phase 4 | — | PETHEMA FoundationOTHER | 1 | Mar 31, 2008 | clinicaltrials |
| NCT00196768 | Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic | unknown | Phase 4 | 30 | German AML Cooperative GroupOTHER | 1 | Oct 23, 2007 | clinicaltrials |
| NCT00411541 | Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia | completed | Phase 4 | 2,600 | International BFM Study GroupNETWORK | 8 | Dec 14, 2006 | clinicaltrials |
| NCT00199147 | Efficacy of G-CSF-Priming in Elderly AML Patients | unknown | Phase 4 | 250 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Oct 26, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 23, 2018source: clinicaltrials